Locations
Houston, TX, USA · Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Research
Size
11-50 employees
Stage
Other
founded in
2016
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. OncoResponse is based in Houston, Texas and Seattle, Washington.
Something looks off?On-site & Remote